Market Place
Sourcing Support
All News #Library
Biotech
Diamyd Secures Expanded Financial Support From Breakthrough T1D
12 Feb 2025 //
PR NEWSWIRE
Diamyd Medical Advances Toward Accelerated Approval for Diamyd
10 Jan 2025 //
PR NEWSWIRE
Diamyd Aligns With FDA On Accelerated Approval Key Points
13 Dec 2024 //
PR NEWSWIRE
Diamyd Medical Reaches Recruitment Milestone in DIAGNODE-3 Phase 3
21 Nov 2024 //
PR NEWSWIRE
Diamyd Medical receives U.S. FDA Fast Track designation for Diamyd®
15 Feb 2024 //
PR NEWSWIRE
Diamyd partners with DiaUnion to recruit participants for diabetes trial
07 Nov 2023 //
PR NEWSWIRE
Diamyd Medical announces a webcast presentation on October 20
17 Oct 2023 //
PR NEWSWIRE
Diamyd partners with JDRF to advance DIAGNODE-3 Phase 3 in Type 1 Diabetes
04 Apr 2023 //
PR NEWSWIRE
Diamyd Medical brings Karin Rosén, M.D, PhD, to its Board of Directors
10 Mar 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.